Acorai

Acorai is developing a device for heart failure management through non-invasive intracardiac pressure monitoring (ICPM), to help reduce hospitalizations and readmissions. Our product can monitor intracardiac pressures non-invasively through a machine learning analysis of pressure dynamics in acoustics, vibratory and waveform data. Our technology show compelling precision, has a low-risk clinical and regulatory pathway, a low dependence on reimbursement and a fast track to commercialization

Cardiology,heart failure,heart failure monitoring,non-invasive intracardiac pressure monitoring,medical device,ai,machine learning,heart failure patient workflow,icpm,prevent heart failure readmissions,multi-sensor hardware,pressure dynamics,clinically proven heart failure vital sign,versatile hardware solution,multi-disciplined senior management,world-leading clinical advisors & partnerships,low risk clinical,regulatory and commercial pathways,cardiovascular,and digital health

Acorai operates in the Medical equipment manufacturing industry.

Acorai's revenue is 11m - 100m

Acorai has 11 - 50 employees.